Generate Biomedicines is trading at $13.88, up 5.06%, as biotech-sector sentiment strengthens.
- Shares rose 6.96% during the October 27 regular session and extended gains after hours.
- XBI gained 2.18%; no confirmed company-specific catalyst for October 27 was identified.
- Latest listed announcements were an October 22 investor-conference notice and an earlier Zealand Pharma collaboration, not a new October 27 announcement.